Abstract: Methods for treating a patient having constipation, the methods including consuming first, a prescribed daily first diet upon waking from sleep that can include specified: a liquid, an oil, a fruit, a vegetable, a first main meal, or a combination thereof; consuming second, a prescribed daily second diet including a salad, oil, and water; consuming third, a prescribed daily second main meal contemporaneously with consuming the salad, or at least 60 to 90 minutes after consuming the salad; consuming fourth, at least a minimum portion of additional water, after waiting a minimum of 45 minutes from consuming the salad, or after waiting 60 to 90 minutes after a main meal, or both; and then exercising or a sedentary waiting, for a period of time, while consuming additional water.

Abstract: The present disclosure relates to extracts of Cordyceps spp., topical formulations containing extracts of Cordyceps spp., methods of formulating the extract and formulations, and methods of use. In one embodiment the Cordyceps spp. is Cordyceps sinensis.

Abstract: A pharmaceutical composition includes a Quisqualis indica extract as an active ingredient, for preventing or treating prostatic hyperplasia, and to a food composition. The Quisqualis indica extract can be favorably used to treat and prevent prostatic hyperplasia by exhibiting effects of a reduction in prostate weight, a reduction in DHT as a prostatic hyperplasia inducing factor, and a reduction in prostate epithelial cell hyperplasia.

Abstract: A method of preventing or inhibiting fungal infestation of plants using an extract of Pyropia yezoensis. In an embodiment, the fungal infestation is caused by Podosphera xanthii. In an embodiment, the plants comprise a cucurbit plant. In an embodiment, the cucurbit plant comprises cucumber.

Abstract: Genetically modified Zymomonas mobilis to utilize inorganic N source, methods and uses thereof are provided. The genetically modified Z. mobilis has a genome with the knockout of a locus ZMO1107 from Z. mobilis ZM4 could ferment inorganic N source.

Abstract: The present invention relates to developing a plant-based composition for arresting the spread of pathogens from an infected person which can be sprayed in infected places, for rapidly decontaminating the affected areas thereby arresting the spread in larger areas which includes include, office complexes, hospitals, schools, mass transportation, prisons, care facilities, public housing, and mass transportation terminals. The present composition is a mixture containing herbs including lavender, Chinese skullcap, black seed oil, Sida acuta, cryptolepis, Isatis, licorice, sage, medicinal honey and ginger in a colloidal silver base.

Abstract: The present invention is directed to methods for collecting and processing autografts, processed autografts, kits for collecting and transporting autografts, and tools for preparing autografts. It is also directed to autologous bone grafts, and methods of preparing them.

Abstract: Provided herein is an injectable composition including, in some embodiments, a soft-tissue augmenting agent and a vehicle for the soft-tissue augmenting agent formulated for augmenting one or more soft tissues of a human or animal. Also provided herein is a soft-tissue augmenting kit including, in some embodiments, a syringe and the injectable composition formulated for augmenting one or more soft tissues of a human or animal. Also provided herein is a method for augmenting one or more soft tissues of a human or animal including, in some embodiments, injecting the injectable composition into the one or more soft tissues of the human or animal.

Abstract: The disclosure provides methods of treating gout in patients comprising administering a PEGylated uricase. Also provided are methods of treating gout in patients comprising co-administering a PEGylated uricase and azathioprine immunosuppressive therapy. Also provided are methods of reducing intolerance or enhancing immuno-tolerance to a PEGylated uricase and prolonging the urate lowering effect comprising co-administration of the PEGylated uricase and azathioprine immunosuppressive therapy.

Abstract: The present invention is a respiratory system protection product and a method for creating said product. The product is created by separating an aloe vera gel from a quantity of aloe vera leaves. The aloe vera gel is added to a heating vessel. A first solution is prepared and added to cover the aloe vera gel. The heating vessel is covered, heated, and stirred until boiling, then removed from heat. After cooling to room temperature an oil component is added. The mixture is blended and amalgamated, then filtered to remove solid materials.

Abstract: The invention relates to an extract of aerial parts of Maca rich in polyphenols, and also to a composition comprising such an extract and, where appropriate, a suitable excipient. The invention also relates to a process for extracting an extract of aerial parts of Maca rich in polyphenols, and also to the extract that can be obtained by means of said process. The invention also relates to such a composition or such an extract for use thereof in preventing or treating disorders or pathological conditions of the skin, the mucous membranes or the superficial body growths and/or for use thereof in preventing and/or treating vascular disorders. Finally, the invention relates to a cosmetic care process for the skin, the superficial body growths or the mucous membranes, with a view to improving the condition thereof or the appearance thereof, which comprises the administration of such a composition or of such an extract.

Abstract: Provided is a method for precipitating a starch emulsion, the method including: mixing a fermentation broth with the starch emulsion, the fermentation broth including an isolated microorganism, wherein the isolated microorganism is Leuconostoc citreum WSJ-57 deposited under an accession number of CGMCC No. 19201 in the China General Microbiological Culture Collection Center on Dec. 20, 2019.

Abstract: The present invention a polyphenol complexes with amino acids, peptides, proteins, glycosaminoglycans, polysaccharides, mucopolysaccharide, disaccharides, monosaccharides, amino sugars, glycol-proteins, DNA/RNA oligonucleotides, mRNA, siRNA, antibodies or other micro- or macro biomolecules.

Abstract: Described herein are dermatological compositions, formulations containing wild type or genetically modified Cutibacterium bacteria and methods for use thereof of skin. The cosmetic and therapeutic formulations described herein can be used as cosmetic daily skin treatments or for treating skin inflammation or disorders including acne, psoriasis, rosacea, dermatitis, or eczema.

Abstract: The present invention relates generally to glutamine-free cell culture media supplemented with asparagine. The invention further concerns the production of recombinant proteins, such as antibodies, in asparagine-supplemented glutamine-free mammalian cell culture.

Abstract: A method for separating a target substance includes: forming a mixture containing: a target substance-magnetic particle complex that includes: a sample containing a target substance, and magnetic particles to which a first receptor is fixed, wherein the first receptor is adapted to specifically recognize a site of the target substance; and separating the target substance-magnetic particle complex from the mixture by magnetism and electrophoresis.

Abstract: A particular composition of the present disclosure is designed to work as a topical composition. The composition relies on a unique combination of any one of, any combination of, or all of Brassica campestris (rapeseed) sterols, Rhododendron ferrugineum extract, Oenothera biennis (evening primrose) oil, and a combination of peptides and polypeptides. The compositions are useful for moisturizing and conditioning the skin.

Abstract: Bacterial hyperswarmers are disclosed for treatment, prevention and diagnosis of conditions such as intestinal inflammation.

Abstract: Compositions, e.g., pharmaceutical compositions, nutritional compositions, medical foods, and food ingredients, as well as their methods of use, are provided, for treating diseases associated with hyperammonemia, e.g., urea cycle disorders (UCD) and hepatic encephalopathy (HE), e.g., minimal HE (MHE) and overt HE (OHE), and modulating enzyme activities and levels of microbes and taxa, and metabolites (e.g., ammonia) in the microbiome of a subject.

Abstract: A traditional Chinese medicine composition for treating dermatophytosis and bromhidrosis, which is prepared from radix sophorae flavescentis and peristrophe japonica, has synergistic interaction and anti-fungal effects, and is not easy to produce drug tolerance. After performing compatibility of extracts of matrine and peristrophe japonica, dermatophytosis and bromhidrosis can be treated, and multiple external preparations can be prepared.